RadNet (NASDAQ:RDNT) Stock Price Crosses Below 50-Day Moving Average – Here’s Why

RadNet, Inc. (NASDAQ:RDNT – Get Free Report)’s stock price passed below its 50-day moving average during trading on Wednesday. The stock has a 50-day moving average of $72.92 and traded as low as $71.50. RadNet shares last traded at $71.82, with a volume of 811,588 shares.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the stock. Truist Financial raised their price objective on shares of RadNet from $90.00 to $94.00 and gave the stock a “buy” rating in a report on Tuesday, August 11th. KeyCorp boosted their target price on shares of RadNet from $92.00 to $95.00 and gave the company an “overweight” rating in a research report on Tuesday, November 10th. Zacks Research cut shares of RadNet from a “strong-buy” rating to a “hold” rating in a report on Monday, November 9th. Raymond James Financial reiterated a “strong-buy” rating on shares of RadNet in a research report on Tuesday, September 22nd. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of RadNet in a research report on Wednesday, November 4th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $89.67.

Check Out Our Latest Report on RadNet

RadNet Stock Down 4.1%

The company has a market capitalization of $5.66 billion, a PE ratio of -247.66 and a beta of 1.42. The company has a debt-to-equity ratio of 0.90, a current ratio of 1.49 and a quick ratio of 1.49. The company has a 50-day moving average of $72.92 and a two-hundred day moving average of $65.56.

RadNet (NASDAQ:RDNT – Get Free Report) last released its quarterly earnings results on Sunday, November 8th. The medical research company reported $0.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $0.08. RadNet had a positive return on equity of 3.14% and a negative net margin of 0.94%. The business had revenue of $638.26 million during the quarter, compared to analyst estimates of $639.97 million. During the same quarter in the previous year, the company posted $0.20 earnings per share. RadNet’s revenue for the quarter was up 22.1% on a year-over-year basis. Sell-side analysts anticipate that RadNet, Inc. will post 0.56 earnings per share for the current fiscal year.

Insider Activity at RadNet

In other news, EVP Mital Patel sold 44,661 shares of RadNet stock in a transaction dated Wednesday, November 11th. The stock was sold at an average price of $78.51, for a total transaction of $3,506,335.11. Following the transaction, the executive vice president directly owned 155,514 shares of the company’s stock, valued at $12,209,404.14. The trade was a 22.31% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 5.14% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Global Retirement Partners LLC raised its stake in RadNet by 285.2% during the 3rd quarter. Global Retirement Partners LLC now owns 470 shares of the medical research company’s stock worth $32,000 after acquiring an additional 348 shares during the period. Farther Finance Advisors LLC lifted its holdings in RadNet by 60.2% during the third quarter. Farther Finance Advisors LLC now owns 596 shares of the medical research company’s stock valued at $41,000 after purchasing an additional 224 shares in the last quarter. Hantz Financial Services Inc. lifted its holdings in RadNet by 18.8% during the third quarter. Hantz Financial Services Inc. now owns 872 shares of the medical research company’s stock valued at $60,000 after purchasing an additional 138 shares in the last quarter. Parallel Advisors LLC boosted its position in shares of RadNet by 80.0% in the first quarter. Parallel Advisors LLC now owns 1,114 shares of the medical research company’s stock worth $62,000 after purchasing an additional 495 shares during the period. Finally, Nykredit A S bought a new position in shares of RadNet in the second quarter worth approximately $153,000. 77.90% of the stock is currently owned by institutional investors.

About RadNet

(Get Free Report)

RadNet, Inc. operates outpatient diagnostic imaging centers in the United States. Its centers provide services including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), mammography, ultrasound, X-ray and nuclear medicine imaging. The company serves patients, physicians and healthcare organizations, with operations across several states, including California, Delaware, Florida, Maryland, New Jersey and New York. Its imaging centers offer diagnostic services for a range of medical needs, from routine screening to specialized examinations.

Read More

Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.